Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity
Yu Nakagama, Katherine Candray, Natsuko Kaku, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 6, pp. 780-787
Open Access | Times Cited: 23

Showing 23 citing articles:

A TriAdj-Adjuvanted Chlamydia trachomatis CPAF Protein Vaccine Is Highly Immunogenic in Pigs
Jessica Proctor, Maria Stadler, Lizette M. Cortes, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 423-423
Open Access | Times Cited: 4
The Durability and Avidity of MPXV-specific Antibodies Induced by the Two-dose MVA-BN Mpox Vaccine
Aaron L. Oom, Angelica C Kottkamp, Kesi K Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Hybrid response to SARS-CoV-2 and Neisseria meningitidis C after an OMV-adjuvanted immunization in mice and their offspring
Amanda Izeli Portilho, Hernan Hermes Monteiro da Costa, Marcia Grando Guereschi, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers
Oladayo A Oyebanji, Nicholas Sundheimer, Vaishnavi Ragavapuram, et al.
GeroScience (2024) Vol. 46, Iss. 6, pp. 6183-6194
Open Access | Times Cited: 2
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection
Sergey V. Kulemzin, Sergey V. Guselnikov, Boris G. Nekrasov, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 55-55
Open Access | Times Cited: 1
A TriAdj-Adjuvanted <em>Chlamydia trachomatis </em>CPAF Protein Vaccine Is Highly Immunogenic in Pigs.
Jessica A Proctor, Maria Stadler, Lizette M. Cortes, et al.
(2024)
Open Access | Times Cited: 1
Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses
Tomoka Matsuura, Wakaba Fukushima, Yu Nakagama, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
An unexpected IgE anti-receptor binding domain response following natural infection and different types of SARS-CoV-2 vaccines
Amanda Izeli Portilho, Valéria Oliveira Silva, Hernan Hermes Monteiro da Costa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route
Marco Polo Peralta Álvarez, Keya Downward, Andrew White, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126444-126444
Open Access | Times Cited: 1
Real-world experience of tixagevimab/cilgavimab prophylaxis in Japanese patients with immunodeficiency
Kento Inoue, Dan Tomomasa, Yu Nakagama, et al.
Journal of Infection and Chemotherapy (2024)
Closed Access | Times Cited: 1
Evolution of global scientific collaboration in mRNA vaccine research: Insights from bibliometric and social network analysis (2010~2023)
Juan Chen, Lizi Pan, Yan Lu, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 4
Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity
Etsuhisa Takahashi, Takako Sawabuchi, Tetsuya Homma, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1662-1662
Open Access | Times Cited: 3
Comparison of Kinetics of Antibody Avidity and IgG Subclasses’ Response in Patients with COVID-19 and Healthy Individuals Vaccinated with the BNT162B2 (Comirnaty, Pfizer/BioNTech) mRNA Vaccine
Waldemar Rastawicki, Rafał Gierczyński, Aleksandra Anna Zasada
Viruses (2023) Vol. 15, Iss. 4, pp. 970-970
Open Access | Times Cited: 2
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents
Jaime S. Rosa Duque, Samuel M. S. Cheng, Carolyn A. Cohen, et al.
World Journal of Pediatrics (2023) Vol. 20, Iss. 4, pp. 353-370
Open Access | Times Cited: 2
An unexpected IgE anti-Receptor binding domain response following natural infection and different types of SARS-CoV-2 vaccines
Amanda Izeli Portilho, Valéria de Oliveira Silva, Hernan Hermes Monteiro da Costa, et al.
Research Square (Research Square) (2024)
Closed Access
The avidity of virus-specific antibodies obtained from <i>in vitro</i> stimulated memory b cells does not change one month after booster with Sputnik V or Comirnaty
Ekaterina A. Astakhova
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 3, pp. 465-470
Open Access
MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
Marco Polo Peralta Álvarez, Keya Downward, Andrew White, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Antibody Avidity Maturation Following Booster Vaccination with an Intranasal Adenovirus Salnavac Vaccine
Ekaterina A. Astakhova, Konstantin O. Baranov, Nadezhda Shilova, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1362-1362
Open Access
Superior antibody and membrane protein-specific T cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents
Jaime S. Rosa Duque, Samuel M. S. Cheng, Carolyn A. Cohen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination
Teresa Harthaller, Barbara Falkensammer, David Bante, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Adjuvant activities of immunostimulating natural products: Astragalus membranaceus (Fisch.) Bge. and Coriolus versicolor in BNT162b2 vaccination against COVID-19 infection
Ben Chung-Lap Chan, Peiting Li, Miranda Sin‐Man Tsang, et al.
Journal of Leukocyte Biology (2023) Vol. 115, Iss. 1, pp. 177-189
Closed Access | Times Cited: 1
Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera
Mayo Yasugi, Yu Nakagama, Natsuko Kaku, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6248-6254
Open Access
Superior neutralizing response after first versus second SARS‐CoV‐2 infection in fully vaccinated individuals
Gonzalo Alonso Rivas, Nuria Labiod, Joanna Luczkowiak, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Open Access
Page 1

Scroll to top